{{Rsnum
|rsid=1794066
|Gene=IL1RN
|Chromosome=2
|position=113128773
|Orientation=plus
|GMAF=0.4963
|Gene_s=IL1RN
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 37.5 | 48.4 | 14.1
| HCB | 20.0 | 40.0 | 40.0
| JPT | 11.1 | 48.9 | 40.0
| YRI | 23.8 | 55.6 | 20.6
| ASW | 0.0 | 0.0 | 0.0
| CHB | 20.0 | 40.0 | 40.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23602982
|Title=IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}